What is it about?
European guidelines recommends testosterone assessment to control advanced prostate cancer during medical treatment. Clinicians should know better testosterone assays characteristics and its implications in analytical results. This article is a brief alert about disparity results between different assays. Maybe your patients aren't well treated dispite an apparently correct blood analyses
Featured Image
Perspectives
This is a first step of a scientific project that aims to verify the correct castration levels during androgen deprivation therapy. In this article we've compared two assays worldwide used to determine serum testosterone. The low concordance between assays alert us about clinicians treatment decisions based on weak reliable results.
Dr Lucas LR Regis
Vall d Hebron University Hospital
Read the Original
This page is a summary of: Behavior of chemiluminescent assays to measure serum testosterone during androgen deprivation therapy, International Journal of Urology, August 2016, Wiley,
DOI: 10.1111/iju.13180.
You can read the full text:
Contributors
The following have contributed to this page
